Jorge Santos-Juanes

16PUBLICATIONS
44CO-AUTHORS
Immunogenetics (incl. genetic immunology)Disease surveillancePredictive and prognostic markersClinical pharmacology and therapeuticsCentral and Eastern European languages (incl. Russian)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 29, 2025
The Age Factor in Ixekizumab Survival: Older Patients Show Higher Long-Term Treatment Survival.

Inés Noval-Martín, Jorge Santos-Juanes, Irene Álvarez-Losada

|Aug 28, 2025
Cutaneous Cancer Trends in Spain: An Emerging Epidemic with Shifting Tumor Types.

Jorge Santos-Juanes, Raquel Santos-Juanes, Marta López-Pando

|Apr 17, 2025
PI3K and PINK1 Immunoexpression as Predictors of Survival in Patients Undergoing Resection of Brain Metastases from Lung Adenocarcinoma.

Miriam Rubiera-Valdés, Mª Daniela Corte-Torres, Andrea Navarro-López

|Jan 25, 2025
Secukinumab for Treatment of Plaque Psoriasis in Real-World Clinical Practice in Spain: A Literature Review.

Esteban Daudén, José María Ortiz-Salvador, Jaime Notario

|May 13, 2024
Sentinel lymph node biopsy versus observation in high-risk cutaneous squamous cell carcinoma in immunosuppressed and immunocompetent patients: An inverse probability of treatment weighting study.

Antonio Tejera-Vaquerizo, Álvaro Gómez-Tomás, Ane Jaka

|Apr 27, 2024
Low-Level Expression of p-S6 Is Associated with Nodal Metastasis in Patients with Head and Neck Cutaneous Squamous Cell Carcinoma.

Celia Gómez-de Castro, Raquel Santos-Juanes, Borja Nuñez-Gómez

Pageof 3

Frequent Collaborators

5 joint publications

Cristina Galache-Osuna

3 joint publications

Iván Fernández-Vega

3 joint publications

Adela Fernández-Velasco

2 joint publications

Noelia Blanco-Agudín